“Virscio is an iterative and open group capable of a lot of great science. Virscio is not just going to run a study in a box; There is the ability to innovate together, and the team is always willing to tweak the disease model to best match your pharmacology.”
– Chief Development Officer, Clinical Stage Biotechnology Company